Posted by taylor@stemsave.com on Sep 25, 2015 2:18:00 PM
Researchers at the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine have investigated the impact of mesenchymal stem cell exosomes in the treatment of chronic non-healing wounds. These conditions affect 6.5 million people with diabetes and paraplegia in the Unites States alone, at an estimated treatment cost of $25 billion per year.
Topics: stemsaveblog, Diabetes, paraplegia, regenerative therapies, growth factors, mesenchymal stem cells, chronic pain, exosome
Researchers at the Cleveland Clinic reported that treating animal subjects with mesenchymal stem cells prevented opioid tolerance despite repeated exposure. Stem cells, when provided after opioid tolerance was established, essentially reversed both tolerance and hypersensitivity to pain associated with opioid tolerance. Although opioids like morphine are essential to the treatment of pain, tolerance requires the use of increasingly higher doses which carry potentially significant morbidity.
Topics: stemsaveblog, inflammation, mesenchymal stem cells, morphine, pain management, opioid, chronic pain
AAOMS - American Association of Oral and Maxillofacial Surgeons
As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.
